home / stock / cue / cue news

CUE News and Press, Cue Biopharma Inc.

Stock Information
Company Name: Cue Biopharma Inc.
Stock Symbol: CUE
Market: NASDAQ
Website: cuebiopharma.com
Menu
CUE CUE Quote CUE Short CUE News CUE Articles CUE Message Board
Get CUE Alerts

News, Short Squeeze, Breakout and More Instantly...
CUE - Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026

BOSTON, March 09, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.  (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune and inflammatory diseases, ...
CUE - Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases

In two non-GLP studies, CUE-401 was well tolerated with no adverse events observed Proof-of-concept studies reinforce promising preclinical profile and therapeutic potential of CUE-401 BOSTON, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.  (Nasdaq: CUE), a clinical-st...

CUE - Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer

BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.  (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune and inflammatory diseases, t...

CUE - US Companies Moving the Markets, Morning edition
Mon, Dec 29, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States PicoCELA Inc. (PCLA) rose 74.5% to $0.405 on volume of 345,086,548 shares Sidus Space Inc. (SIDU) fell 12.3% to $1.93 on volume of 200,695,710 shares Northann Corp. (NCL) rose 23.0% to $0.315 on volume of 181,013,654 shares Can-Fite B...
CUE - Cue Biopharma prices $10M underwritten public offering; shares down

2025-12-19 08:54:59 ET More on Cue Biopharma Cue Biopharma launches proposed public offering of shares and warrants Seeking Alpha’s Quant Rating on Cue Biopharma Historical earnings data for Cue Biopharma Financial information for Cue Biopharma ...

CUE - Cue Biopharma Announces Pricing of $10 Million Public Offering

BOSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease, today announced the pricin...

CUE - Cue Biopharma launches proposed public offering of shares and warrants

2025-12-18 16:07:51 ET More on Cue Biopharma Seeking Alpha’s Quant Rating on Cue Biopharma Historical earnings data for Cue Biopharma Financial information for Cue Biopharma Read the full article on Seeking Alpha For further details see: Cu...
CUE - Expected US Company Earnings on Thursday, November 13th, 2025

GRI Bio Inc. (GRI) is expected to report $-1.11 for Q3 2025 Meridian Mining UK Societas (MRRDF) is expected to report $-0.01 for Q3 2025 CaliberCos Inc. (CWD) is expected to report $-0.32 for Q3 2025 BioCorRx Inc (BICX) is expected to report $-0.06 for Q3 2025 Beneficient (BENF) i...

CUE - Cue Biopharma GAAP EPS of -$0.07 beats by $0.02, revenue of $2.15M misses by $0.14M

2025-11-13 00:49:41 ET More on Cue Biopharma Seeking Alpha’s Quant Rating on Cue Biopharma Historical earnings data for Cue Biopharma Financial information for Cue Biopharma Read the full article on Seeking Alpha For further details see: Cu...

CUE - Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Announced strategic collaboration and license agreement with ImmunoScape to develop breakthrough cell therapy approach for solid tumors – Company is entitled to receive upfront payments totaling $15M Announced strategic transition in leadership to further enable next stage of growt...
Next 10